Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$191.17 - $325.63 $655,139 - $1.12 Million
3,427 Added 9.51%
39,479 $12.9 Million
Q4 2023

Feb 06, 2024

SELL
$160.99 - $215.69 $898,002 - $1.2 Million
-5,578 Reduced 13.4%
36,052 $6.87 Million
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $1.85 Million - $2.7 Million
9,500 Added 29.57%
41,630 $8.29 Million
Q2 2023

Aug 01, 2023

BUY
$223.05 - $302.68 $7.17 Million - $9.73 Million
32,130 New
32,130 $9.17 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Geneva Capital Management LLC Portfolio

Follow Geneva Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.